The Hospital Acquired Disease Testing Market is expected to increase at a CAGR 18.5 percent in forecast period


 Increasing morbidity rates owing to infections, as well as the incidence of pathogens, bacterial, fungal, and viral diseases, are among the key growth factors for the global hospital acquired disease testing market. Another major driver is the growing duration of stay in hospitals, which is mostly due to hospital-acquired infections. In the critical care unit (ICU) and emergency rooms, HAI is more prone to occur (ER). The Centers for Disease Control and Prevention (CDC) in the United States estimates that 5% of patients admitted to hospitals have HAI in some form within 72 hours of their stay. Infections that have been incubating but are not clinically evident at the time of admission are ruled out. Bacterial nosocomial infections are the most common type of illness that spreads in hospitals. When hospital employees do not exercise adequate hygiene and become complacent, these illnesses are routinely transferred.

The hospital-acquired disease testing market is divided into the following segments based on infection types: bloodstream infection (BSI) testing, urinary tract infection (UTI) testing, methicillin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing, and other infections such as cardio vascular infection, gastrointestinal infections, and other infections. The most common type of nosocomial infection is urinary tract infection, which accounts for the majority of the entire HAI testing market. PCR, solid-phase hybridization, and microarrays are common tools for preventing, diagnosing, and treating hospital-associated illnesses.

In 2020, the global market for hospital acquired disease diagnostics will be worth $7.32 billion. The market is expected to increase at a CAGR of 18.5 percent between 2021 and 2026, according to IMARC Group.

The National Health and Medical Research Council of Australia and the Centers for Disease Control and Prevention in the United States have developed a framework of recommendations for healthcare organizations to manage the various types of HAI.

The market for hospital acquired disease testing is dominated by North America, followed by Europe. The Asia-Pacific market is predicted to grow during the forecasted period as the medical tourism industry in Asian countries grows. Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion and Roche are among the market's major players.

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more